title: Infliximab as an alternative treatment for Behçet disease when other therapies fail.
authors.affiliation: Division of Pediatric Gastroenterology, Hepatology and Nutrition, Marmara University School of Medicine, Istanbul, Turkey.
authors.forename: Meltem
authors.initials: M
authors.lastname: Ugras
authors.forename: Deniz
authors.initials: D
authors.lastname: Ertem
authors.forename: Cigdem
authors.initials: C
authors.lastname: Celikel
authors.forename: Ender
authors.initials: E
authors.lastname: Pehlivanoglu
mesh_terms: D000293:Adolescent; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001528:Behcet Syndrome / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D002648:Child; D003113:Colonoscopy; D005260:Female; D006801:Humans; D000069285:Infliximab; D016896:Treatment Outcome; D014456:Ulcer / Q000188:drug therapy / Q000209:etiology / Q000473:pathology
chemical_list: D000911:Antibodies, Monoclonal; D000069285:Infliximab